Marcelo Pasquini, MD, MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    CAR T cells
    Date added:
    08/11/2023
    Date updated:
    08/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Kite Pharma
    Topic:
    CAR T Cells
    Date added:
    08/11/2023
    Date updated:
    08/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Janssen
    Topic:
    CAR T cells
    Date added:
    08/11/2023
    Date updated:
    08/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novartis
    Topic:
    CAR T cells
    Date added:
    08/11/2023
    Date updated:
    08/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Gilead Brazil
    Topic:
    CAR T Cells
    Date added:
    08/11/2023
    Date updated:
    08/11/2023
    Relationship end date:
    08/18/2023
Return to 2023 Wisconsin Multiple Myeloma & Lymphoma Summit